EUCTR2021-003388-90-NL
Active, Not Recruiting
Phase 1
Prospective monitoring of immune response following COVID-19 vaccination in children with cancer - VACCinATE
Princess Máxima Center for Pediatric Oncology0 sites130 target enrollmentJune 21, 2021
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Children with cancer, receiving COVID-19 vaccination
- Sponsor
- Princess Máxima Center for Pediatric Oncology
- Enrollment
- 130
- Status
- Active, Not Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-Willing to receive routine COVID\-19 vaccination with Pfizer or Moderna vaccine as part of the national vaccination program (cohort I)
- •\-Having received SARS\-CoV\-2 vaccination with Pfizer or Moderna as part of the national vaccination program with the last vaccination less than 6 weeks before study entry (cohort II \+ cohort III \+ cohort IV)
- •\-Written informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 130
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range 0
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range 0
Exclusion Criteria
- •\-History of severe adverse reaction associated with a vaccine and/or severe allergic reaction to any component of the study intervention
- •\-Not able to give informed consent (e.g. language problems, illiteracy)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Prospective monitoring of immune response following COVID-19 vaccination in children with cancerNL-OMON52106Prinses Máxima Centrum voor Kinderoncologie130
Active, Not Recruiting
Phase 1
Effectivity of COVID-19 vaccination in people with Down syndromeEUCTR2021-002613-34-NLniversity Medical Center Utrecht640
Recruiting
Phase 4
Prospective monitoring of antibody response following COVID-19 vaccination in patients with Down syndromeNL-OMON54387niversitair Medisch Centrum Utrecht640
Completed
Phase 4
Immune response following COVID-19 vaccination in children with cancer<tr><td>Childhood cancer, Corona vaccination, immune response</td></tr>Childhood cancer, Corona vaccination, immune response10047438NL-OMON21465Princess Máxima Center for Pediatric Oncology130
Recruiting
N/A
Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.Breastcancermammacarcinoma10006291NL-OMON36250Antoni van Leeuwenhoek Ziekenhuis20